Vivacta Limited is a Sittingbourne, UK-based medical diagnostics company that develops an innovative platform for point-of-care testing. Its core technology is a piezofilm platform designed to enable new near‑patient diagnostic products. The company has successfully developed a test for thyroid stimulating hormone (TSH). It is working on a multiple‑analyte cardiovascular diagnostic test intended for emergency room and acute care settings to enable rapid diagnosis of possible heart attack and other time‑critical conditions. In November 2010 Vivacta closed a £4m financing round with participation from existing shareholders. Management stated the fundraising will enable the company to continue to maximize the potential of its platform.

Total raised

$6M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2010